Sepracor Inc.

Sepracor Inc. is a specialty pharmaceutical company with a unique strategy to develop and commercialize potentially improved versions of widely-prescribed drugs referred to as Improved Chemical Entities (ICEs™). Sepracor's ICE Pharmaceuticals are differentiated, proprietary, single-isomer or active-metabolite versions of currently marketed drugs. ICE Pharmaceuticals are designed to offer meaningful improvements in patient outcome through reduced side effects, increased therapeutic efficacy, or improved dosage forms. In some cases, Sepracor's ICE Pharmaceuticals may provide an opportunity for new indications. Sepracor's ICE portfolio focuses on the allergy/asthma, urology/gastroenterology and psychiatry/neurology markets

Activity:

- Manufacturing
- Sales & Distribution

Product / Technology type(s) covered:

- Pharmaceuticals / Therapeutics

Therapeutic targets:

Markets Covered

a. HeadQuarter:

b. Continent(s) active:

c. Countries active:

Corporate data:

Number of Employees:

Turnover:

Amount:	Year:	Currency:

Year founded: